Dr. Xian is an Associate Professor of Neurology and Medicine at the Duke University Medical Center and Duke Clinical Research Institute. He received his Medical Degree from Beijing Medical University (Peking University Health Science Center) and completed his residency at Fuwai Hospital, Peking Union Medical College, and Peking University People’s Hospital. Dr. Xian’s research is dedicated to improving health care quality and outcomes in patients with cardiovascular disease and stroke. He is the principle investigator of two American Heart Association (AHA) grants to study the safety and clinical effectiveness of tissue plasminogen activator in stroke and the ARAMIS Registry of stroke patients on non-vitamin K antagonist oral anticoagulants. Dr. Xian participates on multiple national committees including the AHA’s Get With The Guidelines (GWTG) Quality Improvement Subcommittee, Stroke Systems of Care Advisory Group, Stroke Council’s Quality and Outcomes Committee, Quality of Care and Outcomes Research (QCOR) Council’s Young Clinicians & Investigators Committee, and GWTG-Stroke Clinical Work Group. Dr. Xian has more than 110 published articles in high-tier journals and has been recognized for his research through the AHA QCOR Young Investigator Award and the Northwestern Junior Faculty Clinical Research Award.
Education and Training
- Ph.D., University of Rochester, 2010
- B.M., Beijing Medical University (China), 1999